Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study

Fig. 3

Effect of either 3 × 15 Gy, 10 × 4.5 Gy or 20 × 2.25 Gy fractionation on CLs (a) with VMAT 10MV FFF as treatment modality. 3DCRT did not show a relevant fractionation effect (see Additional file 4). b. PTV volume dependent CL0.5 by treatment modality, based on either 14 cm3, 65 cm3, 114 cm3 or 268 cm3 PTV sizes in the central tumor metastasis

Back to article page